Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Neoplasms 3Prostatic Neoplasms 1Depression 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

enzalutamide 94Magnetic Resonance Spectroscopy 86Specimen Handling 66Prednisone 63Androgen Antagonists 58Abiraterone Acetate 57apalutamide 55Radiosurgery 52darolutamide 49Radiotherapy 47Leuprolide 46abiraterone 45Docetaxel 43Pluvicto 32Biopsy 31acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 30Radiation 30relugolix 28Surveys and Questionnaires 28pembrolizumab 26gallium 68 PSMA-11 26Standard of Care 26Goserelin 25Triptorelin Pamoate 24Gonadotropin-Releasing Hormone 23bicalutamide 22Brachytherapy 21Carboplatin 20cabazitaxel 19X-Rays 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Stress Mindset Measure × 1 year × Clear all
NCT06811454 2026-01-23

Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)

Case Comprehensive Cancer Center

Phase NA Not yet recruiting
76 enrolled
BreastGastrointestinalGenitourinary

Breast Neoplasms, Depression, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡